Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials

被引：0
|
作者：
Strain, W. D. [1 ]
Holst, A. G. [2 ]
Rasmussen, S. [2 ]
Saevereid, H. A. [2 ]
James, M. A. [1 ]
机构：
[1] Univ Exeter, Sch Med, Diabet & Vasc Res Ctr, Exeter, Devon, England
[2] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
258
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [31] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Peter Rossing
    Stephen C. Bain
    Heidrun Bosch-Traberg
    Ekaterina Sokareva
    Hiddo J. L. Heerspink
    Søren Rasmussen
    Linda G. Mellbin
    Cardiovascular Diabetology, 22
  • [32] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Rossing, Peter
    Bain, Stephen C.
    Bosch-Traberg, Heidrun
    Sokareva, Ekaterina
    Heerspink, Hiddo J. L.
    Rasmussen, Soren
    Mellbin, Linda G.
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [33] Semaglutide reduced cardiovascular events regardless of metformin use: a post hoc exploratory subgroup analysis of SUSTAIN 6 and PIONEER
    Husain, M.
    Consoli, A.
    De Remigis, A.
    Meyer, A. S. P.
    Rasmussen, S.
    Bain, S.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 14 - 14
  • [34] Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Mellbin, L. G.
    Bhatt, D. L.
    David, J. -P.
    Petrie, M. C.
    Rasmussen, S.
    Schytz, P. A.
    Vilsboll, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S305
  • [35] Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Cherney, David
    Bosch-Traberg, Heidrun
    Hadjadj, Samy
    Kuhlman, Anja B.
    Rasmussen, Soren
    Tuttle, Katherine R.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [36] Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
    Husain, Mansoor
    Bain, Stephen C.
    Holst, Anders Gaarsdal
    Mark, Thomas
    Rasmussen, Soren
    Lingvay, Ildiko
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [37] Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials
    Mansoor Husain
    Stephen C. Bain
    Anders Gaarsdal Holst
    Thomas Mark
    Søren Rasmussen
    Ildiko Lingvay
    Cardiovascular Diabetology, 19
  • [38] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial
    Verma, Subodh
    Poulter, Neil R.
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Leiter, Lawrence A.
    Nauck, Michael A.
    Pratley, Richard E.
    Zinman, Bernard
    Orsted, David D.
    Fries, Tea Monk
    Rasmussen, Soren
    Marso, Steven P.
    CIRCULATION, 2018, 138 (25) : 2884 - 2894
  • [39] Liraglutide and semaglutide improve cardiovascular and renal outcomes across baseline BP categories: analysis of LEADER and SUSTAIN 6
    Leiter, L. A.
    Bain, S. C.
    Bhatt, D. L.
    Buse, J. B.
    Mazer, C. D.
    Pratley, R.
    Lindberg, S.
    Rasmussen, S.
    Vrazic, H.
    Verma, S.
    DIABETOLOGIA, 2019, 62 : S364 - S365
  • [40] Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
    Wang, Jingyu
    Yang, Juhong
    Jiang, Wenhui
    Liu, Wenyan
    Shen, Zewei
    Gao, Zhongai
    Chang, Baocheng
    DIABETES OBESITY & METABOLISM, 2024,
12345